The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 22, 2021

Filed:

Sep. 30, 2017
Applicants:

Centre National DE LA Recherche Scientifique, Paris, FR;

Université DE Montpellier, Montpellier, FR;

Inventors:

Monsef Benkirane, Saint Gely du Fesc, FR;

Gael Petitjean, Montpellier, FR;

Benjamin Descours, Montpellier, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/569 (2006.01); C12N 5/0783 (2010.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
G01N 33/56988 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 16/283 (2013.01); C07K 16/2809 (2013.01); C12N 5/0636 (2013.01); C07K 2317/31 (2013.01); C12N 2501/2302 (2013.01); C12N 2501/515 (2013.01); C12N 2501/53 (2013.01); G01N 2333/7051 (2013.01); G01N 2333/70514 (2013.01); G01N 2333/70535 (2013.01); G01N 2800/26 (2013.01); G01N 2800/54 (2013.01);
Abstract

The use of differentiation marker CD89 for the detection of cellular reservoirs of a mammalian immunodeficiency virus. Also the use of the differentiation marker CD89 for making a prognosis, diagnosing a remission, and evaluating the efficacy of treatment of the mammalian immunodeficiency. A multi-specific antibody that recognizes both at least one epitope of CD89 and at least one characteristic of the lymphocyte cells, a composition including the antibody, and the use of the antibody for treatment.


Find Patent Forward Citations

Loading…